- Medigus (NASDAQ:MDGS) +49% on large order for visualization device.
- VivoPower (NASDAQ:VVPR) +48% on FY result.
- HOOKIPA Pharma (NASDAQ:HOOK) +29% on go with study of HB-201 in HPV+ cancers.
- Milacron Holdings (NYSE:MCRN) +23% on being acquired by Hillenbrand.
- Oasmia Pharmaceutical AB (NASDAQ:OASM) +22%.
- Uxin (NASDAQ:UXIN) +10% on divesting loan facilitation related business to Golden Pacer.
- Ritter Pharmaceuticals (NASDAQ:RTTR) +7% on regaining compliance with Nasdaq’s minimum bid price requirement.
- Stitch Fix (NASDAQ:SFIX) +6% after Goldman Sachs nod.
- RedHill Biopharma (NASDAQ:RDHL) +5%.